Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/20223922

Blood 2010 May 20 115 20 4061-70

Download in:

View as

General Info

PMID
20223922